DEXCOM INC 8-K

What Happened

• DexCom, Inc. announced its financial results for the quarter and the full year ended December 31, 2025 via a press release dated February 12, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K (Item 2.02) filed with the SEC. The filing was signed by Jereme M. Sylvain, Executive Vice President and Chief Financial Officer, on February 12, 2026.

Key Details

• Filing date: February 12, 2026 (Form 8-K, Item 2.02).
• Reporting period: quarter and year ended December 31, 2025.
• Exhibit: Press release announcing results furnished as Exhibit 99.1.
• Administrative: 8-K signed by Jereme M. Sylvain, EVP & CFO; Exhibit 104 (Inline XBRL cover page) also included.

Why It Matters

• This 8-K is the company’s official SEC notice that DexCom has released its latest quarterly and annual operating results — material information investors use to assess recent performance.
• Retail investors should read the attached press release (Exhibit 99.1) and related investor materials (earnings release, presentation, or call transcript) for revenue, earnings, guidance, and other financial metrics that could affect the stock.